Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities and schizophrenia.

A S Bassett1, E W Chow, R Weksberg

  • 1Department of Psychiatry, University of Toronto, Canada.

American Journal of Medical Genetics
|May 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An online survey to understand the needs of caregivers of family members with 22q11 deletion syndrome.

Journal of intellectual disability research : JIDR·2023
Same author

The COVID-19 pandemic's impact on worry and medical disruptions reported by individuals with chromosome 22q11.2 copy number variants and their caregivers.

Journal of intellectual disability research : JIDR·2022
Same author

Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.

Clinical epigenetics·2019
Same author

Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia.

Psychological medicine·2018
Same author

A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.

Molecular psychiatry·2017
Same author

Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.

Psychological medicine·2017
Same journal

Abstracts for the Xth World Congress of Psychiatric Genetics. Brussels, Belgium, 9-13 October 2002.

American journal of medical genetics·2003
Same journal

Defects of blastogenesis.

American journal of medical genetics·2002
Same journal

Malformations of the craniofacial region: evolutionary, embryonic, genetic, and clinical perspectives.

American journal of medical genetics·2002
Same journal

Limb anomalies: Developmental and evolutionary aspects.

American journal of medical genetics·2002
Same journal

Molecular etiology of gut malformations and diseases.

American journal of medical genetics·2002
Same journal

Status of the human malformation map: 2002.

American journal of medical genetics·2002
See all related articles

Chromosomal abnormalities, particularly 22q11.2 microdeletions, are linked to schizophrenia. Advanced techniques like fluorescence in-situ hybridization (FISH) aid in identifying these genetic links in psychiatric patients.

Area of Science:

  • Psychiatry
  • Genetics
  • Cytogenetics

Background:

  • Schizophrenia is a complex psychiatric disorder with a strong genetic basis, though specific genetic loci remain elusive.
  • Chromosomal abnormalities offer potential insights into the genetic architecture of schizophrenia.
  • Understanding these abnormalities is crucial for advancing genetic studies and gene localization.

Purpose of the Study:

  • To review and synthesize evidence linking chromosomal abnormalities with schizophrenia and related disorders.
  • To highlight the role of molecular cytogenetic techniques in identifying genetic associations.
  • To emphasize the importance of considering genetic syndromes in psychiatric patients.

Main Methods:

  • Review of existing literature on chromosomal abnormalities and schizophrenia.

Related Experiment Videos

  • Analysis of studies utilizing fluorescence in-situ hybridization (FISH) for detecting microdeletions.
  • Examination of data on sex chromosome abnormalities in schizophrenia patients.

    • Main Results:

    • Significant association found between 22q11.2 microdeletions and schizophrenia.
    • Increased prevalence of sex chromosome abnormalities in schizophrenia noted, but further data is needed.
    • Molecular cytogenetics, especially FISH, has increased the identification rate of abnormalities in schizophrenia, particularly in specific patient subgroups.

    Conclusions:

    • 22q11.2 microdeletions are a key finding in schizophrenia genetic research.
    • Clinicians should consider chromosomal abnormalities and genetic syndromes in selected psychiatric patients.
    • Behavioral phenotypes should be considered within the context of genetic syndromes.